# Neuroendocrine Brake for Type 2 Diabetes Mellitus

> **NCT00450710** · PHASE4 · COMPLETED · sponsor: **Medtronic - MITG** · enrollment: 40 (—)

## Conditions studied

- Diabetes

## Interventions

- **PROCEDURE:** ileal interposition with a sleeve gastrectomy

## Key facts

- **NCT ID:** NCT00450710
- **Lead sponsor:** Medtronic - MITG
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-03
- **Primary completion:** 2008-09
- **Final completion:** 2009-09
- **Target enrollment:** 40 (—)
- **Last updated:** 2014-08-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00450710

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00450710, "Neuroendocrine Brake for Type 2 Diabetes Mellitus". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT00450710. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*